Published in Lancet on September 19, 1987
Rash and pulmonary eosinophilia associated with fenbufen. BMJ (1990) 0.84
Prognostic value of tumour-infiltrating lymphocytes (TILs) in colorectal cancer. J Pathol (1997) 3.09
Outcome and resource utilization in gastroenterological surgery. Br J Surg (2001) 2.67
Lymphocyte infiltrates as a prognostic variable in female breast cancer. Eur J Cancer (1992) 1.96
A survey of sudden death associated with the use of antipsychotic or antidepressant drugs: 49 cases in Finland. Acta Psychiatr Scand (1991) 1.74
Bone densitometry of the spine and femur in children by dual-energy x-ray absorptiometry. Bone Miner (1992) 1.61
Tumor cell-associated hyaluronan as an unfavorable prognostic factor in colorectal cancer. Cancer Res (1998) 1.59
Adenovirus-mediated gene transfer to lower limb artery of patients with chronic critical leg ischemia. Hum Gene Ther (1998) 1.45
A potentially hazardous interaction between erythromycin and midazolam. Clin Pharmacol Ther (1993) 1.45
The effect of dobutamine infusion on splanchnic blood flow and oxygen transport in patients with acute pancreatitis. Intensive Care Med (1997) 1.42
Osteoporosis in adult patients with celiac disease. Bone (1999) 1.41
[Consumption of psychotropic drugs in Finland, Iceland, Norway and Sweden]. Nord Med (1977) 1.40
Agranulocytosis during treatment with chlozapine. Eur J Clin Pharmacol (1977) 1.36
Letter: Clozapine and agranulocytosis. Lancet (1975) 1.28
Possible teratogenicity of imipramine-chloropyramine. Lancet (1973) 1.26
Bone mineral density and risk factors for osteoporosis--a population-based study of 1600 perimenopausal women. Calcif Tissue Int (1994) 1.24
Apelin, orexin-A and leptin plasma levels in morbid obesity and effect of gastric banding. Regul Pept (2005) 1.21
Macrolide-resistant Streptococcus pneumoniae and use of antimicrobial agents. Clin Infect Dis (2001) 1.19
Bone density at the proximal femur after total hip arthroplasty. Clin Orthop Relat Res (1998) 1.19
Multicenter clinical trials and their value in assessing total joint arthroplasty. Clin Orthop Relat Res (1989) 1.15
The reaction of ferrocytochrome c with cytochrome oxidase: A new look. FEBS Lett (1972) 1.13
Hormone receptors as prognostic factors in female breast cancer. Ann Med (1991) 1.12
The progression of burn depth in experimental burns: a histological and methodological study. Burns (2004) 1.12
Bone recovery after a gluten-free diet: a 5-year follow-up study. Bone (1999) 1.11
Systemic and regional effects of experimental gradual splanchnic ischemia. J Crit Care (1997) 1.11
Dose of midazolam should be reduced during diltiazem and verapamil treatments. Br J Clin Pharmacol (1994) 1.11
Ultrasonography, CT, and ERCP in the diagnosis of choledochal stones. Acta Radiol (1992) 1.11
Calcaneal ultrasound predicts early postmenopausal fractures as well as axial BMD. A prospective study of 422 women. Osteoporos Int (2004) 1.10
Balloon angioplasty enhances the expression of angiotensin II AT1 receptors in neointima of rat aorta. J Clin Invest (1992) 1.09
The effect of gynecological risk factors on lumbar and femoral bone mineral density in peri- and postmenopausal women. Maturitas (1995) 1.09
Angiotensin-II receptor subtypes in fetal tissue of the rat: autoradiography, guanine nucleotide sensitivity, and association with phosphoinositide hydrolysis. Endocrinology (1991) 1.08
Risk factors for perimenopausal fractures: a prospective study. Osteoporos Int (2000) 1.03
Sterol regulatory element binding protein 1c (SREBP-1c) expression in human obesity. Obes Res (2001) 1.02
Decreased axial bone mineral density in perimenopausal women with rheumatoid arthritis--a population based study. Ann Rheum Dis (1994) 1.01
Relationships between risk factors and fractures differ by type of fracture: a population-based study of 12,192 perimenopausal women. Osteoporos Int (1998) 1.01
Cardiovascular death among women under 40 years of age using low-estrogen oral contraceptives and intrauterine devices in Finland from 1975 to 1984. Am J Obstet Gynecol (1990) 1.01
Association between functional capacity tests and fractures: an eight-year prospective population-based cohort study. Osteoporos Int (2008) 0.99
Long-term results from laparoscopic common bile duct exploration. Surg Endosc (2003) 0.99
Intestinal luminal microdialysis: a new approach to assess gut mucosal ischemia. Anesthesiology (1999) 0.99
Cocaine N-demethylation and the metabolism-related hepatotoxicity can be prevented by cytochrome P450 3A inhibitors. Eur J Pharmacol (1994) 0.99
Expression of CD44 and variant proteins in human colorectal cancer and its relevance for prognosis. Scand J Gastroenterol (1998) 0.99
Trabecular bone mineral density of mandible and alveolar height in postmenopausal women. Scand J Dent Res (1993) 0.99
Prevention of femoral and lumbar bone loss with hormone replacement therapy and vitamin D3 in early postmenopausal women: a population-based 5-year randomized trial. J Clin Endocrinol Metab (1999) 0.98
Antibiotic use by indication: a basis for active antibiotic policy in the community. Scand J Infect Dis (2001) 0.97
Risk factors for perimenopausal distal forearm fracture. Osteoporos Int (2000) 0.96
Actions and interactions with alcohol of drugs on psychomotor skills: comparison of diazepam and gamma-hydroxybutyric acid. Arch Int Pharmacodyn Ther (1978) 0.96
Tofisopam, a novel 3,4-benzodiazepine: multiple-dose effects on psychomotor skills and memory. Comparison with diazepam and interactions with ethanol. Psychopharmacology (Berl) (1980) 0.96
Measurement of bone density around total knee arthroplasty using fan-beam dual energy X-ray absorptiometry. Calcif Tissue Int (2000) 0.95
Microangiopathy in acute acalculous cholecystitis. Br J Surg (1997) 0.95
Serum osteocalcin and carboxyterminal propeptide of type I procollagen in rheumatoid arthritis. Ann Rheum Dis (1993) 0.95
Fractures and low axial bone density in perimenopausal women. J Clin Epidemiol (1995) 0.94
Effects of alcohol on buspirone and lorazepam actions. Clin Pharmacol Ther (1982) 0.94
Determinants of bone mineral density in middle aged men: a population-based study. Osteoporos Int (2000) 0.94
HRT and Vit D in prevention of non-vertebral fractures in postmenopausal women; a 5 year randomized trial. Maturitas (1998) 0.93
Development of bone mass and bone density of the spine and femoral neck--a prospective study of 65 children and adolescents. Bone Miner (1993) 0.93
Clinical evaluation of a new serum tumour marker CA 242 in pancreatic carcinoma. Br J Cancer (1992) 0.93
Prediction of fracture risk using axial bone mineral density in a perimenopausal population: a prospective study. J Bone Miner Res (1995) 0.93
Distribution of tritiated-1 delta 9tetrahydrocannabinol in rat tissues after inhalation. J Pharm Pharmacol (1970) 0.92
Cortical bone mineral density in the mandible and osteoporosis status in postmenopausal women. Scand J Dent Res (1993) 0.91
Biosynthetic human growth hormone preserves both muscle protein synthesis and the decrease in muscle-free glutamine, and improves whole-body nitrogen economy after operation. Ann Surg (1992) 0.91
The kinetics of the anaerobic reduction of fungal laccase B. Eur J Biochem (1973) 0.90
Development of tolerance and cross-tolerance to the psychomotor actions of lorazepam and diazepam in man. Br J Clin Pharmacol (1983) 0.90
Piperacillin/tazobactam versus imipenem/cilastatin in the treatment of intra-abdominal infections. Surg Gynecol Obstet (1993) 0.90
Caffeine antagonizes diazepam effects in man. Med Biol (1982) 0.90
Prevention of systemic hyperlactatemia during splanchnic ischemia. Shock (2000) 0.89
Risks of perimenopausal fractures--a prospective population-based study. Acta Obstet Gynecol Scand (1995) 0.89
Angiotensin II receptor subtypes and phosphoinositide hydrolysis in rat adrenal medulla. Brain Res Bull (1995) 0.89
Bone mineral metabolism after total gastrectomy. Bone (2001) 0.89
Tumor vascularity and basement membrane structure as prognostic factors in T1-2MO prostatic adenocarcinoma. Anticancer Res (1994) 0.88
Clinical contribution of bcl-2, p53 and Ki-67 proteins in pancreatic ductal adenocarcinoma. Anticancer Res (1998) 0.88
Osteoporosis risk factors, gynaecological history and fractures in perimenopausal women--the results of the baseline postal enquiry of the Kuopio Osteoporosis Risk Factor and Prevention Study. Maturitas (1993) 0.88
Ethanol inhibits melatonin secretion in healthy volunteers in a dose-dependent randomized double blind cross-over study. J Clin Endocrinol Metab (1993) 0.88
Nitrofurantoin-induced acute, subacute and chronic pulmonary reactions. Scand J Respir Dis (1977) 0.88
Lifestyle and other factors predict ankle fractures in perimenopausal women: a population-based prospective cohort study. Bone (2002) 0.88
Lymphoma of the breast. Ann Chir Gynaecol (1989) 0.88
Expression of CD44 and its variant isoform v3 has no prognostic value in gastric cancer. Histopathology (2001) 0.87
Long-term results of Charnley arthroplasty. A 12-16-year follow-up study. J Arthroplasty (1994) 0.87
Tumor size, nuclear morphometry, mitotic indices as prognostic factors in axillary-lymph-node-positive breast cancer. Eur Surg Res (1992) 0.87
Objective and subjective assessment of hangover during subacute administration of temazepam and nitrazepam to healthy subjects. Eur J Clin Pharmacol (1984) 0.87
Effects on learning and memory of 2-week treatments with chlordiazepoxide lactam, N-desmethyldiazepam, oxazepam and methyloxazepam, alone or in combination with alcohol. Int Pharmacopsychiatry (1979) 0.86
The contribution of the active metabolites to the tolerance developing to diazepam in man: relationship to bioassayed serum benzodiazepine levels. Med Biol (1984) 0.86
Acute abdominal pain in adults. Ann Chir Gynaecol (1996) 0.86
Red blood cell and tissue water content in experimental thermal injury. Burns (2005) 0.86
Effect of calcium and vitamin D supplementation on bone mineral density in women aged 65-71 years: a 3-year randomized population-based trial (OSTPRE-FPS). Osteoporos Int (2010) 0.86
Multivariate analysis of six serum tumor markers (CEA, CA 50, CA 242, TPA, TPS, TATI) and conventional laboratory tests in the diagnosis of hepatopancreatobiliary malignancy. Anticancer Res (1996) 0.85
Acetylation pattern of different sulphonamides in rapid and slow isoniazid inactivators. Ann Med Exp Biol Fenn (1969) 0.85
Receiver operating characteristic (ROC) curve analysis of the tumour markers CEA, CA 50 and CA 242 in pancreatic cancer; results from a prospective study. Br J Cancer (1993) 0.85
Cemented first-time revisions of the femoral component: prospective 7 to 13 years' follow-up using second-generation and third-generation technique. J Arthroplasty (2000) 0.85
The inhibition of CYP enzymes in mouse and human liver by pilocarpine. Br J Pharmacol (1995) 0.85
Regular physical exercise and bone mineral density: a four-year controlled randomized trial in middle-aged men. The DNASCO study. Osteoporos Int (2001) 0.85
Type-1 and type-2 angiotensin II receptors in fetal rat brain. Eur J Pharmacol (1991) 0.84
Prognostic factors in axillary lymph node-negative (pN-) breast carcinomas. Eur J Cancer (1991) 0.84
Metabolism of harmaline in rats. Biochem Pharmacol (1971) 0.84
Effect of time interval between food and drug ingestion on the absorption of oxybutynin from a controlled-release tablet. Pharmacol Toxicol (1997) 0.84
Associations of early premenopausal fractures with subsequent fractures vary by sites and mechanisms of fractures. Calcif Tissue Int (1997) 0.84
The effect of previous oral contraceptive use on bone mineral density in perimenopausal women. Osteoporos Int (1994) 0.84